INIS
antigens
100%
immunity
100%
vaccines
100%
protection
100%
gold
100%
lipopolysaccharides
40%
diseases
30%
humans
30%
proteins
20%
animals
20%
range
20%
delivery
20%
lethals
20%
interventions
10%
cytokines
10%
macrophages
10%
mortality
10%
africa
10%
asia
10%
pathogens
10%
life cycle
10%
uptake
10%
antibiotics
10%
latin america
10%
australia
10%
bacillus
10%
hemagglutinins
10%
tropical regions
10%
nanoparticles
10%
roads
10%
Immunology and Microbiology
Antigen Specificity
100%
Immunity
100%
Vaccine Efficacy
100%
Burkholderia pseudomallei
100%
Glycoconjugate
100%
Development
33%
Antigen
33%
Animal
22%
Adoptive Immunity
22%
T Cell
11%
Human
11%
Cytokine
11%
Cells
11%
Macrophage
11%
Mortality Rate
11%
Infectious Agent
11%
Life Cycle
11%
Subunit Vaccine
11%
Titer
11%
Immunoglobulin A
11%
Gram-Negative Bacteria
11%
Hemagglutinin
11%
Burkholderia thailandensis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antigen
100%
Vaccine
100%
Glycoconjugate
100%
Burkholderia pseudomallei
100%
Lipopolysaccharide
44%
Melioidosis
44%
Diseases
33%
Protein
22%
Animal
22%
Gold Nanoparticle
22%
Human
11%
Cytokine
11%
Infection
11%
Infectious Agent
11%
Complication
11%
Subunit Vaccine
11%
Fatality
11%
Antibiotic Agent
11%
Mortality Rate
11%
Gram Negative Bacterium
11%
Immunoglobulin A
11%
Hemagglutinin
11%
Intrinsic Resistance
11%
Endemic Disease
11%
Gold Nanoparticle
11%
Burkholderia thailandensis
11%
Keyphrases
Complex Human Disease
20%
Bacterial Cell Cycle
20%
Biochemistry, Genetics and Molecular Biology
Burkholderia thailandensis
25%
Medicine and Dentistry
Burkholderia thailandensis
11%